PERSPECTA

News from every angle

← Back to headlines

End of Apogee Drug Collaboration Leads to Revised Analyst Expectations

The conclusion of a drug collaboration for Apogee (APGE) has prompted analysts to revise their expectations for the company.

19 Feb, 00:39 — 19 Feb, 00:39
PostShare
Only 1 source covers this story